Gene expression profiling identifies Fibronectin 1 and CXCL9 as candidate biomarkers for breast cancer screening.
about
Pathway-based classification of cancer subtypes.Proteomic identification of plasma protein tyrosine phosphatase alpha and fibronectin associated with liver fluke, Opisthorchis viverrini, infection.Gene expression profiling for the purposes of biomarker discovery in oral potentially malignant lesions: a systematic review.Serum CXCL9 levels are associated with tumor progression and treatment outcome in patients with nasopharyngeal carcinomaHypoxia and free radicals: role in tumor progression and the use of engineering-based platforms to address these relationships.Evaluating Serum Markers for Hormone Receptor-Negative Breast Cancer.Modulation of CXCR3 ligand secretion by prostaglandin E2 and cyclooxygenase inhibitors in human breast cancer.Global profiling of prolactin-modulated transcripts in breast cancer in vivo.CXCL9: evidence and contradictions for its role in tumor progression.Biomarkers in the diagnosis of primary and recurrent breast cancer.BCLAF1 and its splicing regulator SRSF10 regulate the tumorigenic potential of colon cancer cells.A three-gene signature from protein-protein interaction network of LOXL2- and actin-related proteins for esophageal squamous cell carcinoma prognosis.Secretome analysis of Glioblastoma cell line--HNGC-2.MicroRNA-139 targets fibronectin 1 to inhibit papillary thyroid carcinoma progression.
P2860
Q30527843-6D59303E-40FC-4260-9959-398ECBDB0A7FQ34429098-CDA86760-1757-4CB0-A4DA-DEEAD8532001Q34657641-B424F118-73FF-4E3E-B254-264BBA3FE5D0Q35053419-BBE96D46-8A7B-40B0-9E80-DB6AD24A01DAQ35117865-D1281AA2-D763-44F9-BBEC-B17AB314048CQ35840714-8414905C-08EC-4179-981A-5943E1E4DEEEQ36393212-B111664C-1048-43CA-97B6-ADD7739E2737Q36952878-D1FA1A53-2B8F-43C3-9BDE-9EF3BBFB1977Q37429985-011BA91D-2426-4D87-9F37-67BA80CD3B0CQ38052925-0866BEAB-EFCF-4AD4-B253-0ECDE17B43F2Q38305268-F0B94844-EEC1-41A5-8D9D-BFAFBA2474CDQ38757261-19C65DF8-9204-4156-8DD3-83094B8E1341Q39182040-EE22F643-D130-4FC3-BB93-27E4E4272536Q47097250-910F68FE-FDB8-49D8-96C8-5A8557E25C90
P2860
Gene expression profiling identifies Fibronectin 1 and CXCL9 as candidate biomarkers for breast cancer screening.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Gene expression profiling iden ...... s for breast cancer screening.
@ast
Gene expression profiling iden ...... s for breast cancer screening.
@en
type
label
Gene expression profiling iden ...... s for breast cancer screening.
@ast
Gene expression profiling iden ...... s for breast cancer screening.
@en
prefLabel
Gene expression profiling iden ...... s for breast cancer screening.
@ast
Gene expression profiling iden ...... s for breast cancer screening.
@en
P2093
P2860
P356
P1476
Gene expression profiling iden ...... s for breast cancer screening.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6605511
P407
P577
2010-01-12T00:00:00Z
P5875
P6179
1052498977